GB202215115D0 - VEGF antibodies - Google Patents

VEGF antibodies

Info

Publication number
GB202215115D0
GB202215115D0 GBGB2215115.3A GB202215115A GB202215115D0 GB 202215115 D0 GB202215115 D0 GB 202215115D0 GB 202215115 A GB202215115 A GB 202215115A GB 202215115 D0 GB202215115 D0 GB 202215115D0
Authority
GB
United Kingdom
Prior art keywords
vegf antibodies
vegf
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB2215115.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GBGB2215115.3A priority Critical patent/GB202215115D0/en
Publication of GB202215115D0 publication Critical patent/GB202215115D0/en
Priority to PCT/GB2023/052666 priority patent/WO2024079482A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565—Complementarity determining region [CDR]
GBGB2215115.3A 2022-10-13 2022-10-13 VEGF antibodies Pending GB202215115D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB2215115.3A GB202215115D0 (en) 2022-10-13 2022-10-13 VEGF antibodies
PCT/GB2023/052666 WO2024079482A1 (en) 2022-10-13 2023-10-13 Vegf antibodies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2215115.3A GB202215115D0 (en) 2022-10-13 2022-10-13 VEGF antibodies

Publications (1)

Publication Number Publication Date
GB202215115D0 true GB202215115D0 (en) 2022-11-30

Family

ID=84818408

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2215115.3A Pending GB202215115D0 (en) 2022-10-13 2022-10-13 VEGF antibodies

Country Status (2)

Country Link
GB (1) GB202215115D0 (en)
WO (1) WO2024079482A1 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
SE459005B (en) 1985-07-12 1989-05-29 Aake Rikard Lindahl SET TO MANUFACTURE SPHERICAL POLYMER PARTICLES
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
ATE255131T1 (en) 1991-06-14 2003-12-15 Genentech Inc HUMANIZED HEREGULIN ANTIBODIES
AU3374795A (en) 1994-08-29 1996-03-22 Prizm Pharmaceuticals, Inc. Conjugates of vascular endothelial growth factor with targeted agents
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
WO2004006955A1 (en) 2001-07-12 2004-01-22 Jefferson Foote Super humanized antibodies
GB201006096D0 (en) 2010-04-13 2010-05-26 Alligator Bioscience Ab Novel compositions and uses thereof
US20150353617A1 (en) * 2013-01-27 2015-12-10 The Cleveland Clinic Foundation Anti-angiogenic vegf-ax isoform

Also Published As

Publication number Publication date
WO2024079482A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
GB202105110D0 (en) Anti-CD73 antibodies
GB202215115D0 (en) VEGF antibodies
GB202014851D0 (en) SARS-COV-2 antibodies
GB2614651B (en) Antibodies
GB202400120D0 (en) Anti-pgdh antibodies
GB202319255D0 (en) Anti-UNC5C antibodies
GB202318820D0 (en) Antibodies
GB202317371D0 (en) Anti-unc5c antibodies
GB202317192D0 (en) Anti-agr2 antibodies
GB202317188D0 (en) Anti-AGR2 antibodies
GB202317187D0 (en) Anti-AGR2 antibodies
GB202317189D0 (en) Anti-AGR2 antibodies
GB202316016D0 (en) Antibodies
GB202311473D0 (en) Anti-ifnl1/reg3a antibodies
GB202311470D0 (en) Anti-BST2 antibodies
GB202309920D0 (en) Antibodies
GB202308898D0 (en) Anti-fibril antibodies
GB202308884D0 (en) Anti-fibril antibodies
GB202306874D0 (en) Antibodies
GB202306051D0 (en) Antibodies
GB202304512D0 (en) Antibodies
GB202301959D0 (en) Antibodies
GB202301823D0 (en) Antibodies
GB202300873D0 (en) Antibodies
GB202217924D0 (en) Antibodies